Biogena Taps Herbst Kinsky for EUR 10 Million Bond Issuance
Deal News | May 07, 2025 | CEE Legal Matters
Herbst Kinsky, an Austrian law firm, has been instrumental in advising the Biogena Group, an Austrian company known for developing and distributing health and nutrition products, on critical financial transactions over the years. The latest advisory involved a EUR 10 million bond issuance in 2023. Previously, the law firm assisted Biogena with a crowd investment via Rockets Investments in 2023, and a capital increase in 2021. In 2020, Herbst Kinsky also advised on Biogena's IPO and its listing on the Vienna Stock Exchange. However, Herbst Kinsky has not commented on their involvement.
Sectors
- Legal Advisory
- Health and Nutrition
- Capital Markets
Geography
- Austria – Both Biogena and Herbst Kinsky operate out of Austria, and the bond issuance is likely centered in the Austrian market.
Industry
- Legal Advisory – Herbst Kinsky is providing legal advisory services to Biogena in their financial transactions.
- Health and Nutrition – Biogena is involved in developing and distributing health and nutrition products.
- Capital Markets – The issuance of bonds and prior capital market activities, including IPO and capital increase, involve this sector.
Financials
- EUR 10 Million – The value of the bond issuance advised by Herbst Kinsky for Biogena in 2023.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Biogena Group | Target Company | Company | An Austrian developer and distributor of health and nutrition products. |
| Herbst Kinsky | Legal Advisor | Company | An Austrian law firm advising Biogena on its financial transactions. |
| Rockets Investments | Bidding Company | Company | Involved in Biogena's crowd investment. |